259 related articles for article (PubMed ID: 8349327)
1. Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
Burnier M; Rutschmann B; Nussberger J; Versaggi J; Shahinfar S; Waeber B; Brunner HR
Hypertension; 1993 Sep; 22(3):339-47. PubMed ID: 8349327
[TBL] [Abstract][Full Text] [Related]
2. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
[TBL] [Abstract][Full Text] [Related]
3. Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems.
Burnier M; Pechère-Bertschi A; Nussberger J; Waeber B; Brunner HR
Am J Kidney Dis; 1995 Jul; 26(1):108-15. PubMed ID: 7611241
[TBL] [Abstract][Full Text] [Related]
4. Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat.
Macari D; Bottari S; Whitebread S; De Gasparo M; Levens N
Eur J Pharmacol; 1993 Nov; 249(1):85-93. PubMed ID: 8282023
[TBL] [Abstract][Full Text] [Related]
5. Acute renal effects of AT1-receptor blockade after exogenous angiotensin II infusion in healthy subjects.
Schmitt F; Martinez F; Brillet G; Nguyen-Khoa T; Brouard R; Sissmann J; Lacour B; Grunfeld JP
J Cardiovasc Pharmacol; 1998 Feb; 31(2):314-21. PubMed ID: 9475275
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic and renal responses to oral losartan potassium during salt depletion or salt repletion in normal human volunteers.
Doig JK; MacFadyen RJ; Sweet CS; Reid JL
J Cardiovasc Pharmacol; 1995 Apr; 25(4):511-7. PubMed ID: 7596116
[TBL] [Abstract][Full Text] [Related]
7. Dose-ranging study of the angiotensin type I receptor antagonist losartan (DuP753/MK954), in salt-deplete normal man.
Doig JK; MacFadyen RJ; Sweet CS; Lees KR; Reid JL
J Cardiovasc Pharmacol; 1993 May; 21(5):732-8. PubMed ID: 7685442
[TBL] [Abstract][Full Text] [Related]
8. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.
Goldberg MR; Tanaka W; Barchowsky A; Bradstreet TE; McCrea J; Lo MW; McWilliams EJ; Bjornsson TD
Hypertension; 1993 May; 21(5):704-13. PubMed ID: 8491505
[TBL] [Abstract][Full Text] [Related]
9. Effects of losartan on renal function in patients with essential hypertension.
Fauvel JP; Velon S; Berra N; Pozet N; Madonna O; Zech P; Laville M
J Cardiovasc Pharmacol; 1996 Aug; 28(2):259-63. PubMed ID: 8856482
[TBL] [Abstract][Full Text] [Related]
10. Renal-specific actions of angiotensin II receptor antagonism in the anesthetized dog.
Chan DP; Sandok EK; Aarhus LL; Heublein DM; Burnett JC
Am J Hypertens; 1992 Jun; 5(6 Pt 1):354-60. PubMed ID: 1524759
[TBL] [Abstract][Full Text] [Related]
11. Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects.
Burnier M; Hagman M; Nussberger J; Biollaz J; Armagnac C; Brouard R; Weber B; Brunner HR
Hypertension; 1995 Apr; 25(4 Pt 1):602-9. PubMed ID: 7721404
[TBL] [Abstract][Full Text] [Related]
12. Effect of losartan and enalapril on renal adaptation sodium restriction in rat.
Jover B; Saladini D; Nafrialdi N; Dupont M; Mimran A
Am J Physiol; 1994 Aug; 267(2 Pt 2):F281-8. PubMed ID: 8067389
[TBL] [Abstract][Full Text] [Related]
13. Effect of sympathetic and angiotensin-aldosterone systems on renal salt conservation in the rat.
Honrath U; Veress AT; Chong CK; Sonnenberg H
Am J Physiol; 1997 Apr; 272(4 Pt 2):F538-44. PubMed ID: 9140056
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II blockade does not prevent renal effects of L-NAME in sodium-repleted humans.
Montanari A; Tateo E; Fasoli E; Giberti D; Perinotto P; Novarini A; Dall'Aglio P
Hypertension; 1997 Sep; 30(3 Pt 2):557-62. PubMed ID: 9322981
[TBL] [Abstract][Full Text] [Related]
15. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog.
MacFadyen RJ; Tree M; Lever AF; Reid JL
Clin Sci (Lond); 1992 Nov; 83(5):549-56. PubMed ID: 1335390
[TBL] [Abstract][Full Text] [Related]
16. Effects of EXP3174, a non-peptide angiotensin II receptor antagonist, on renal hemodynamics and renal function in dogs.
Tamaki T; Nishiyama A; Yoshida H; He H; Fukui T; Yamamoto A; Aki Y; Kimura S; Iwao H; Miyatake A
Eur J Pharmacol; 1993 May; 236(1):15-21. PubMed ID: 8319740
[TBL] [Abstract][Full Text] [Related]
17. Losartan blocks aldosterone and renal vascular responses to angiotensin II in humans.
Gandhi SK; Ryder DH; Brown NJ
Hypertension; 1996 Dec; 28(6):961-6. PubMed ID: 8952583
[TBL] [Abstract][Full Text] [Related]
18. Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands.
Keiser JA; Bjork FA; Hodges JC; Taylor DG
J Pharmacol Exp Ther; 1992 Sep; 262(3):1154-60. PubMed ID: 1527720
[TBL] [Abstract][Full Text] [Related]
19. Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system.
Munger KA; Jackson EK
Am J Physiol; 1994 Nov; 267(5 Pt 2):F783-90. PubMed ID: 7977781
[TBL] [Abstract][Full Text] [Related]
20. Modification of pressure natriuresis by long-term losartan in spontaneously hypertensive rats.
Kline RL; Liu F
Hypertension; 1994 Oct; 24(4):467-73. PubMed ID: 8088913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
